Neutrophil Extracellular Traps in Pediatric Inflammatory Bowel Disease: A Potential Role in Ulcerative Colitis

Rachel Shukrun1,2,3, Victoria Fidel1, Szilvia Baron1

  • 1Pediatric Hemato-Oncology Research Laboratory, Tel Aviv Medical Center, Tel Aviv 6423906, Israel.

Insights

Neutrophil extracellular traps (NETs) are elevated in pediatric inflammatory bowel disease (IBD) biopsies and blood, particularly in ulcerative colitis (UC). NET formation normalized in UC patients who achieved remission, suggesting a potential therapeutic target.

Area of Science:

  • Gastroenterology
  • Immunology
  • Pediatrics

Background:

  • Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is a chronic gut inflammation affecting children and adults.
  • Neutrophil extracellular traps (NETs) are neutrophil-derived structures implicated in tissue damage in various inflammatory conditions.

Purpose of the Study:

  • To investigate the presence and role of NETs in pediatric IBD.
  • To compare NET levels in intestinal biopsies and peripheral blood of pediatric IBD patients with healthy controls.

Main Methods:

  • Analysis of intestinal biopsies and peripheral blood from 20 pediatric IBD patients (CD and UC) and controls.
  • Assessment of neutrophil infiltration and NET formation using biopsy staining and neutrophil activation assays.
  • Measurement of NET protein enzymatic activity and evaluation of NET formation in UC patients during remission.

Main Results:

  • Pediatric IBD biopsies (both UC and CD) showed significantly higher neutrophil and NET levels than controls.
  • Ulcerative colitis (UC) demonstrated the strongest association with increased NETs.
  • Peripheral blood neutrophils from newly diagnosed UC patients exhibited heightened NET formation compared to controls and CD patients.
  • NET formation in UC patients returned to normal levels after successful remission-inducing treatment.

Conclusions:

  • NETs may play a significant role in the pathogenesis of pediatric IBD, especially UC.
  • Further research is warranted to elucidate NET mechanisms in pediatric IBD.
  • Targeting NET formation could represent a novel therapeutic strategy for pediatric IBD.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
146
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
322
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
189
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
117